Hepatitis C Epidemiology: Insights from a Comprehensive Cohort Study in ASST Melegnano and Martesana, Lombardia Region, Northern Italy

Michele Nardone,Dario Di Stasio,Alberta Lucchese,Daniele Gentili,Giulia Cattabianchi,Carlo Signorelli,Pierangelo Sarchi,Giovanna Pulcrano,Valentino Lembo,Paola Maria Pirola,Dorina Lauritano,Francesco Carinci,Dario Di Di Stasio
DOI: https://doi.org/10.3390/pathogens13030215
IF: 3.7
2024-02-29
Pathogens
Abstract:Hepatitis C virus (HCV) infection is a significant public health problem affecting 58 million people worldwide, including 3.9 million in Europe. Many of these infections go undiagnosed because chronic infection is often asymptomatic. This observational cohort study presents a detailed examination of hepatitis C virus epidemiology in Lombardia (Italy) and was conducted within the ASST "Melegnano e della Martesana". The study involved comprehensive HCV screening of 3290 patients accessing the collection points and/or hospitalized in the facilities of the ASST from 20 May 2022 to 13 April 2023. Screening was conducted using serological assays. The prevalence of anti-HCV-positive patients (HCV-Ab) and then HCV-positive patients (RNA) was calculated. Chi-square tests examined the associations between continuous and categorical variables. Logistic regression was used to evaluate the influence of demographic and geographic variables as predictors of HCV positivity. The study revealed an overall HCV-Ab prevalence of 0.912% (CI (0.59%–1.24%)) in the examined cohort, of whom 15.15% (two females and three males) were positive for HCV RNA. The prevalence of HCV RNA positivity was 0.152% (CI (0.05%–0.35%)). Sex disparity was evident, with male patients exhibiting a higher prevalence compared to females, confirmed by logistic regression (0.0147 vs. 0.0061 – OR = 2.44; CI (0.0059–0.0124)). Age stratification indicated an ascending trend in prevalence with age, peaking at 1.35% in individuals aged over 50. These findings underscore the critical need for targeted HCV screening, contributing valuable insights to the global epidemiology of HCV in the era of DAAs.
microbiology
What problem does this paper attempt to address?
The problem this paper attempts to address is the epidemiological characteristics of Hepatitis C Virus (HCV) infection in the Lombardy region of Italy. Specifically, the main objective of the study is to calculate the prevalence of HCV infection in the sample population by screening at specific local health service agencies (ASST). The study also explores the differences in HCV infection across different age groups, genders, and regions, and analyzes the impact of these variables on HCV positive results. The main research contents include: 1. **Screening Methods**: The study uses serological testing methods to screen for HCV antibodies (HCV-Ab) and further conducts HCV RNA testing on antibody-positive samples to confirm active infection. 2. **Sample Selection**: The study subjects are patients who visited or were hospitalized at ASST Melegnano and Martesana from May 20, 2022, to April 13, 2023. 3. **Statistical Analysis**: The associations between continuous and categorical variables were analyzed using chi-square tests and logistic regression models, evaluating the role of demographic and geographic variables as predictors of HCV positivity. The study results indicate: - The overall HCV antibody positivity rate is 0.912%, with a higher prevalence in male patients compared to females (1.47% vs 0.61%). - The prevalence of HCV infection increases with age, peaking in individuals over 50 years old (1.35%). - There are significant differences in prevalence across different geographic regions, with the highest in the Peschiera area (2.532%), while no cases were found in some other areas. These findings help in formulating targeted screening programs for specific populations and regions, thereby better controlling HCV infection.